Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. junior Avg
|
New words:
Acrivon, allotted, appeal, Aprea, assay, ASU, awaiting, Bio, BioCity, Biopharma, BioScience, BIOSECURE, blood, boost, bridge, Cancer, carbon, certiorari, cGMP, charge, Chia, Chinese, Circuit, climate, confirming, Debiopharm, destined, disposition, downstream, ease, economy, entirety, environmental, ethical, Exploratory, extreme, FASB, fundamentally, highest, HotSpot, house, HTA, inconvenient, indirect, Inductive, infeasible, influential, Ireland, Lin, linked, Lorton, macroeconomic, marker, media, MHRA, mifepristone, modulation, nonrenewal, onsite, pathway, Patrick, permanently, petition, PhRMA, precipitation, preparatory, prioritization, procurement, quantitative, quantity, reconciling, recovery, Repare, robust, run, running, SA, schema, Senate, sentiment, Shouyao, signaling, slightly, solid, spent, stakeholder, stay, stayed, sue, Tai, Tianqing, tightly, UK, uninsured, weather, Windsor, writ
Removed:
accessible, acting, augment, built, CMC, Colorado, corrected, deployed, DNA, efficiency, generic, Hampshire, hedging, homology, inadequate, insufficiently, Janssen, Johnson, lab, labor, Maine, Mexico, newly, partnered, Pharma, regime, remediating, remediation, repeated, selected, SIP, targeting, tied, understatement, Vermont, Zai
Filing tables
Filing exhibits
Related press release
Associated SDGR transcripts
SDGR similar filings
Filing view
External links